Swedish Orphan Biovitrum is a Swedish biopharmaceutical company focused on the development and commercialization of innovative treatments for rare diseases, particularly in hematology and immunology.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!